Juhyuk Park
Research Subjects
Research Interests
Juhyuk Park has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Arthur Swift
Swift Beauty Clinic, Quebec, Canada
1 shared publication - Han Earl Lee
Opening Plastic Surgery Clinic, Seoul 06038, Republic of Korea
1 shared publication Hongseok Kim
VOS Dermatology Clinic, Seoul, Korea
1 shared publication- Isabella Rosellini
Avery Clinic, Malang, Indonesia
1 shared publication - Jin-Hyun Kim
You and I Clinic, Seoul, Korea
1 shared publication - Jong Keun Song
Pixelab Plastic Surgery Clinic, Seoul, korea
1 shared publication
Latest Publications
- 7 January 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (11) , 4212-4217
Comparative Pain Assessment of Intradermal Versus Subdermal Skin Booster Injections Using PDLLA: A Randomized, Double-Blinded Split-Injection Study
Background Poly-D,L-lactic acid (PDLLA) skin boosters are widely used for biostimulatory skin rejuvenation, but comparative data on pain perception between injection techniques remain limited. Objective To compare patient-reported pain between intradermal and subdermal PDLLA injections using a randomized, double-blinded, split-injection design. Methods Twenty-one healthy participants (aged 27–64) each received ten facial injections: five intradermal and five subdermal, administered in randomized order using a 32G needle. Pain was assessed using a Visual Analogue Scale (VAS) immediately after each injection. The primary outcome was the difference in mean VAS scores between techniques. Secondary analyses examined the effects of age and gender on pain perception. Results The mean VAS score for intradermal injections was significantly higher than for subdermal injections (6.18 vs. 3.85, p<0.001). No significant gender-based differences were observed. Patients under 40 reported higher intradermal pain than older subjects (p=0.04), but age had no impact on subdermal pain. Conclusion Subdermal PDLLA injections are significantly less painful than intradermal injections, likely due to lower nerve density and reduced dermal resistance. With equivalent efficacy and minimal downtime, subdermal injection may be preferable for patient comfort and compliance. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authorswww.springer.com/00266
- 7 January 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (11) , 4212-4217
Comparative Pain Assessment of Intradermal Versus Subdermal Skin Booster Injections Using PDLLA: A Randomized, Double-Blinded Split-Injection Study
Background Poly-D,L-lactic acid (PDLLA) skin boosters are widely used for biostimulatory skin rejuvenation, but comparative data on pain perception between injection techniques remain limited. Objective To compare patient-reported pain between intradermal and subdermal PDLLA injections using a randomized, double-blinded, split-injection design. Methods Twenty-one healthy participants (aged 27–64) each received ten facial injections: five intradermal and five subdermal, administered in randomized order using a 32G needle. Pain was assessed using a Visual Analogue Scale (VAS) immediately after each injection. The primary outcome was the difference in mean VAS scores between techniques. Secondary analyses examined the effects of age and gender on pain perception. Results The mean VAS score for intradermal injections was significantly higher than for subdermal injections (6.18 vs. 3.85, p<0.001). No significant gender-based differences were observed. Patients under 40 reported higher intradermal pain than older subjects (p=0.04), but age had no impact on subdermal pain. Conclusion Subdermal PDLLA injections are significantly less painful than intradermal injections, likely due to lower nerve density and reduced dermal resistance. With equivalent efficacy and minimal downtime, subdermal injection may be preferable for patient comfort and compliance. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authorswww.springer.com/00266